TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/19 11:02 | 11/15/19 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beechey Robert Harry | TX | O | CFO | P | 4 | 0.7083 | 0 | 5 | 2 | 210 | D | ||||||||||||||
5/17/19 12:26 | 5/17/19 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beechey Robert Harry | TX | O | CFO | P | 6 | 1.26 | 0 | 5 | 3 | 205 | D | ||||||||||||||
12/6/18 16:23 | 12/6/18 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beechey Robert Harry | TX | O | CFO | P | 14 | 0.5700 | 0 | 25 | 14 | 200 | D | ||||||||||||||
8/23/18 16:10 | 8/23/18 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beechey Robert Harry | TX | O | CFO | P | 46 | 0.6100 | 0 | 75 | 75 | 175 | D | ||||||||||||||
8/16/18 16:11 | 8/14/18 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Beechey Robert Harry | TX | O | CFO | P | 52 | 0.5200 | 0 | 100 | New | 100 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |